Christopher Jessen, DNP

NPI: 1639793649
Total Payments
$633.28
2024 Payments
$194.81
Companies
6
Transactions
17
Medicare Patients
1,463
Medicare Billing
$66,394

Payment Breakdown by Category

Food & Beverage$533.29 (84.2%)
Education$99.99 (15.8%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $533.29 16 84.2%
Education $99.99 1 15.8%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $317.98 6 $0 (2024)
Janssen Biotech, Inc. $141.86 3 $0 (2024)
Ortho Dermatologics, a division of Bausch Health US, LLC $59.94 3 $0 (2024)
Lilly USA, LLC $44.17 2 $0 (2024)
Helsinn Therapeutics (U.S.), Inc. $39.56 1 $0 (2021)
Galderma Laboratories, L.P. $29.77 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $194.81 5 Janssen Biotech, Inc. ($99.99)
2023 $198.32 7 ABBVIE INC. ($105.94)
2022 $200.59 4 ABBVIE INC. ($179.21)
2021 $39.56 1 Helsinn Therapeutics (U.S.), Inc. ($39.56)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/15/2024 Lilly USA, LLC EBGLYSS (Drug) Food and Beverage In-kind items and services $25.91 General
Category: Immunology
10/09/2024 Ortho Dermatologics, a division of Bausch Health US, LLC Cabtreo (Drug) Food and Beverage In-kind items and services $20.76 General
Category: Dermatology
09/17/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $15.32 General
05/21/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $32.83 General
Category: IMMUNOLOGY
05/08/2024 Janssen Biotech, Inc. TREMFYA (Drug) Education In-kind items and services $99.99 General
Category: Immunology
10/25/2023 Galderma Laboratories, L.P. AKLIEF (Drug) Food and Beverage In-kind items and services $14.45 General
Category: ACNE
09/12/2023 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $23.08 General
Category: Immunology
07/12/2023 Ortho Dermatologics, a division of Bausch Health US, LLC JUBLIA (Drug) Food and Beverage In-kind items and services $17.80 General
Category: Podiatry
05/17/2023 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $18.26 General
Category: Immunology
05/17/2023 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $14.51 General
Category: IMMUNOLOGY
03/09/2023 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $91.43 General
Category: IMMUNOLOGY
02/20/2023 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $18.79 General
Category: Immunology
12/07/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $29.17 General
Category: IMMUNOLOGY
08/30/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $26.17 General
Category: IMMUNOLOGY
07/19/2022 Ortho Dermatologics, a division of Bausch Health US, LLC JUBLIA (Drug) Food and Beverage In-kind items and services $21.38 General
Category: Podiatry
03/16/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $123.87 General
Category: IMMUNOLOGY
10/28/2021 Helsinn Therapeutics (U.S.), Inc. VALCHLOR (Drug) Food and Beverage In-kind items and services $39.56 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 864 1,700 $211,900 $40,955
2022 9 599 1,052 $132,839 $25,439
Total Patients
1,463
Total Services
2,752
Medicare Billing
$66,394
Procedure Codes
33

All Medicare Procedures & Services

33 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 144 203 $33,056 $9,884 29.9%
17000 Destruction of precancer skin growth, 1 growth Office 2023 133 165 $29,266 $4,845 16.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 43 64 $15,167 $4,160 27.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 74 74 $17,188 $3,763 21.9%
11102 Biopsy of related skin growth, first growth Office 2023 89 103 $31,724 $3,679 11.6%
17004 Destruction of precancer skin growth, 15 or more growths Office 2023 30 39 $15,052 $3,008 20.0%
17110 Destruction of skin growth, 1-14 growths Office 2023 49 59 $14,211 $2,914 20.5%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 101 620 $11,129 $1,803 16.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 43 53 $8,522 $1,678 19.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 17 17 $6,119 $1,400 22.9%
17000 Destruction of precancer skin growth, 1 growth Facility 2023 36 42 $7,450 $1,138 15.3%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 22 22 $5,068 $994.23 19.6%
11103 Biopsy of related skin growth, each additional growth Office 2023 20 27 $4,485 $676.47 15.1%
17110 Destruction of skin growth, 1-14 growths Facility 2023 15 16 $3,854 $532.08 13.8%
11102 Biopsy of related skin growth, first growth Facility 2023 19 21 $6,468 $273.39 4.2%
17003 Destruction of precancer skin growth, 2-14 growths Facility 2023 29 175 $3,141 $208.03 6.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 55 62 $9,603 $3,448 35.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 61 78 $11,942 $2,933 24.6%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2022 49 49 $10,964 $2,130 19.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 35 35 $7,832 $2,083 26.6%
17000 Destruction of precancer skin growth, 1 growth Facility 2022 63 70 $12,416 $2,009 16.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 15 27 $6,058 $1,998 33.0%
17004 Destruction of precancer skin growth, 15 or more growths Office 2022 19 20 $7,719 $1,875 24.3%
17110 Destruction of skin growth, 1-14 growths Office 2022 22 27 $6,503 $1,808 27.8%
11102 Biopsy of related skin growth, first growth Office 2022 35 37 $11,396 $1,772 15.5%

About Christopher Jessen, DNP

Christopher Jessen, DNP is a Family healthcare provider based in Sandy, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2020. The National Provider Identifier (NPI) number assigned to this provider is 1639793649.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Jessen, DNP has received a total of $633.28 in payments from pharmaceutical and medical device companies, with $194.81 received in 2024. These payments were reported across 17 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($533.29).

As a Medicare-enrolled provider, Jessen has provided services to 1,463 Medicare beneficiaries, totaling 2,752 services with total Medicare billing of $66,394. Data is available for 2 years (2022–2023), covering 33 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Sandy, UT
  • Active Since 06/05/2020
  • Last Updated 10/21/2021
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1639793649

Products in Payments

  • SKYRIZI (Biological) $303.47
  • TREMFYA (Drug) $141.86
  • VALCHLOR (Drug) $39.56
  • JUBLIA (Drug) $39.18
  • EBGLYSS (Drug) $25.91
  • Cabtreo (Drug) $20.76
  • TALTZ (Drug) $18.26
  • RINVOQ (Biological) $14.51
  • AKLIEF (Drug) $14.45

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Sandy